Aspira Women's Health Inc. (AWHL): Long-Term Debt
$1.28M
As of 2025-12-31
$1.16M
As of 2026-06-30
-22.3%
3-year compound annual growth
-20.9%
5-year compound annual growth
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.28M | -15.3% | 2026-04-01, Balance as of period end |
| 2024-12-31 | $1.51M | -5.6% | 2026-04-01, Balance as of period end |
| 2023-12-31 | $1.60M | -41.3% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $2.72M | -6.9% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $2.92M | -29.2% | 2023-10-26, Balance as of period end |
| 2020-12-31 | $4.12M | n/c | 2022-03-31, Balance as of period end |
| 2019-12-31 | $1.29M | n/a | 2021-03-31, Balance as of period end |
| No annual figure between 2010-12-31 and 2019-12-31. | |||
| 2010-12-31 | $7.00M | n/a | 2012-03-27, Balance as of period end |
Long-Term Debt at similar companies
| Company | Year ended | Long-Term Debt | Change YoY |
|---|---|---|---|
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $1.28M | -15.3% |
| Immucell Corp (ICCC) | 2025-12-31 | $9.10M | n/a |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $13.12M | +39.0% |
| Volitionrx Ltd (VNRX) | 2025-12-31 | $6.71M | +39.4% |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $119.90M | n/a |
| QuidelOrtho Corp (QDEL) | 2025-12-28 | $2.70B | +8.4% |
| Idexx Laboratories Inc (IDXX) | 2025-12-31 | $450.00M | -27.2% |
Compare AWHL, ICCC, TKNO, VNRX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗